These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4742499)

  • 1. Treatment of advanced neoplastic disease with 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037).
    DeConti RC; Hubbard SP; Pinch P; Bertino JR
    Cancer Chemother Rep; 1973 Apr; 57(2):201-7. PubMed ID: 4742499
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer.
    Perloff M; Muggia FM; Ackerman C
    Cancer Chemother Rep; 1974; 58(3):421-4. PubMed ID: 4841718
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy with adriamycin (NSC-123127) and 1-(2-chloroethyl)-3-cyclohexyl 1-nitrosourea (CCNU; NSC-79037).
    Einhorn LH; Livingston RB; Gottlieb JA
    Cancer Chemother Rep; 1973; 57(4):437-45. PubMed ID: 4586951
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of solid tumors and lymphomas with methyl-CCNU (NSC-95441): a phase II study.
    Firat D; Tekuzman G
    Cancer Chemother Rep; 1975; 59(5):1021-3. PubMed ID: 1106843
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrosoureas: a reappraisal of clinical trials.
    Katz ME; Glick JH
    Cancer Clin Trials; 1979; 2(4):297-316. PubMed ID: 394866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary clinical trial of 1-(2-chlorethyl)-3-(4-methylcyclohexyl)-1 nitrosourea (NSC-95411) (MeCCNU) in human neoplasms.
    Gailani S; Kutcher J
    J Med; 1973; 4(4):209-18. PubMed ID: 4520348
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
    Rosenblum ML; Reynolds AF; Smith KA; Rumack BH; Walker MD
    J Neurosurg; 1973 Sep; 39(3):306-14. PubMed ID: 4354763
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer.
    Klaassen DJ; Rapp E
    Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU).
    Young RC; Walker MD; Canellos GP; Schein PS; Chabner BA; DeVita VT
    Cancer; 1973 May; 31(5):1164-9. PubMed ID: 4705154
    [No Abstract]   [Full Text] [Related]  

  • 10. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Engstrom PF; Catalano RB; Creech RH
    Cancer Treat Rep; 1976 Mar; 60(3):285-7. PubMed ID: 1260784
    [No Abstract]   [Full Text] [Related]  

  • 12. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 13. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
    Broder LE; Hansen HH
    Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
    [No Abstract]   [Full Text] [Related]  

  • 14. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic disposition of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (Me CCNU) in man.
    Sponzo RW; DeVita VT; Oliverio VT
    Cancer; 1973 May; 31(5):1154-6. PubMed ID: 4705152
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer.
    Rossi A; Riva A; Bonadonna G
    Cancer Chemother Rep; 1975; 59(6):1161-2. PubMed ID: 769958
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.
    Lokich JJ; Skarin AT
    Cancer Chemother Rep; 1972 Oct; 56(5):653-7. PubMed ID: 4569058
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 20. CCNU (1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II study.
    Hoogstraten B; Gottlieb JA; Caoili E; Tucker WG; Talley RW; Haut A
    Cancer; 1973 Jul; 32(1):38-43. PubMed ID: 4716783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.